Overview

Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether mesalamine is effective vs. placebo in the prevention of diverticulitis flares in a 24-months follow-up. The primary end-point of the study is the incidence of diverticulitis flares. Will be made a clinical diagnosis of uncomplicated diverticulitis: fever, leukocytosis, abdominal pain and altered intestinal motility.
Phase:
Phase 3
Details
Lead Sponsor:
SOFAR S.p.A.
Treatments:
Mesalamine